Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AJJ Medtech Holdings Limited ( (SG:584) ) has issued an update.
AJJ Medtech Holdings Limited, through its wholly owned subsidiary AJJ Healthcare Management, has secured a four-year supply contract worth about S$3 million with a network of Singapore healthcare institutions. The deal covers biodegradable medical consumables and further entrenches the group’s role as a key supplier to institutional healthcare customers.
Together with other recently won multi-year tenders for medical and laboratory consumables, AJJ Medtech’s institutional revenue pipeline now exceeds S$8 million to be recognized over three- to five-year terms. The growing order book improves recurring revenue visibility, demonstrates the group’s competitive strength in tender processes, and aligns its operations with the healthcare sector’s shift toward more sustainable procurement practices.
More about AJJ Medtech Holdings Limited
AJJ Medtech Holdings Limited is a Singapore-based medical technology group listed on SGX, operating through its subsidiary AJJ Healthcare Management to supply medical and laboratory consumables. The company focuses on serving institutional healthcare and academic customers, with an increasing emphasis on sustainable, biodegradable medical products within Singapore’s healthcare ecosystem.
Average Trading Volume: 11,328,878
Technical Sentiment Signal: Sell
Current Market Cap: S$11.98M
See more data about 584 stock on TipRanks’ Stock Analysis page.